News and Events
The University of Minnesota College of Pharmacy and its consortium partners have received a $1 million Health Resources & Services Administration (HRSA) grant for substance use prevention, intervention, recovery and harm reduction for the Bois Forte Nation.
Over the past few months, a number of drugs have been under investigation to treat COVID-19 without well-established safety or data to support these claims. However, some of these unproven therapies may have underlying genetic reasons for not being effective and resulting in fatal adverse effects as found with hydroxychloroquine.
Md Abdullah Al Noman, PhD candidate, has been named a 2020 Male Contraceptive Initiative (MCI) Fellow by the Male Contraceptive Initiative.
Dr. Andrew Traynor, PharmD, BCPS, has accepted the position of assistant dean of experiential education, effective June 30, 2020. He also holds a faculty appointment in the Department of Pharmaceutical Care & Health Systems.
The University of Minnesota has received a $1 million philanthropic investment from the Otto Bremer Trust to establish mobile healthcare services in communities that lack access to medical care because of COVID-19, civil unrest related to racial injustice as well as economic and other factors.
IV Baclofen, a muscle relaxant drug, benefits individuals who experience dystonia (abnormal muscle tension) or spasticity (muscle stiffness or rigidity) caused by cerebral palsy, multiple sclerosis, brain or spinal cord injury. The drug is currently available as oral tablets and as an intrathecal solution delivered through a pump into the spinal column.
Laura Palombi is the 2020 recipient University of Minnesota President's Community-Engaged Scholar Award.
Amy Pittenger receives the University of Minnesota 2020 President’s Award for Outstanding Service.